Indian J Palliat Care Home 
 

CASE REPORT
Year : 2020  |  Volume : 26  |  Issue : 3  |  Page : 381--384

Effectiveness of gabapentinoids for cancer-related rectal and vesical tenesmus: Report of four cases

Keita Tagami1, Masaru Yoshizumi2, Akira Inoue3, Motohiro Matoba4 
1 Department of Palliative Medicine, Tohoku University School of Medicine, Sendai; Department of Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan
2 Department of Physiology and Anatomy, Tohoku Medical and Pharmaceutical University, Sendai, Japan
3 Department of Palliative Medicine, Tohoku University School of Medicine, Sendai, Japan
4 Department of Palliative Medicine, National Cancer Center Hospital, Tokyo; Department of Palliative Medicine, Aomori Prefectural Central Hospital, Aomori, Japan

Correspondence Address:
Keita Tagami
Department of Palliative Medicine, Tohoku University School of Medicine, 2-1 Seiryo-Machi, Aoba-ku, Sendai, Miyagi 980-8575
Japan

Gabapentinoids could be assumed to relieve cancer-related rectal/vesical tenesmus based on their pharmacological mechanism. Four patients were refractory for cancer-related rectal/vesical tenesmus although their opioid doses were titrated up. Symptom intensity difference (SID) between initiation and follow-up after 24, 48, and 72 h and daily changes in the frequency of urination, defecation, opioid rescue doses, presence of sleep disruption, and dose of regular opioid medication were evaluated. The median reductions in daily discomfort measured as SID between baseline and follow-up after 24, 48, and 72 h were 87.5%, 70.0%, and 80.0%, respectively, while those in daily pain intensity were 75%, 66.7%, and 66.7%, respectively. The initiation dose of gabapentin was 200 or 400 mg/day and that of pregabalin was 75 mg/day in one patient. Gabapentinoids were effective at low doses administered over a short duration to patients with refractory cancer-related rectal/vesical tenesmus.


How to cite this article:
Tagami K, Yoshizumi M, Inoue A, Matoba M. Effectiveness of gabapentinoids for cancer-related rectal and vesical tenesmus: Report of four cases.Indian J Palliat Care 2020;26:381-384


How to cite this URL:
Tagami K, Yoshizumi M, Inoue A, Matoba M. Effectiveness of gabapentinoids for cancer-related rectal and vesical tenesmus: Report of four cases. Indian J Palliat Care [serial online] 2020 [cited 2020 Dec 1 ];26:381-384
Available from: https://www.jpalliativecare.com/article.asp?issn=0973-1075;year=2020;volume=26;issue=3;spage=381;epage=384;aulast=Tagami;type=0